Fiasp ultra-fast-acting FlexTouch
Fiasp ultra-fast-acting FlexTouch is a medicine authorised by Swissmedic under authorisation number 66200. The authorisation holder is Novo Nordisk Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 June 2017 and the authorisation is valid without a time limit. ATC code A10AB05 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 66200 |
|---|---|
| Name | Fiasp ultra-fast-acting FlexTouch |
| Full name | Fiasp ultra-fast-acting FlexTouch, Injektionslösung |
| Authorisation holder | Novo Nordisk Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10AB05 |
| First authorisation | 07 June 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Fiasp ultra-fast-acting FlexTouch, Injektionslösung | B | 07 June 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 x 3 | ml | A10AB05 | 07.06.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Fiasp ultra-fast-acting FlexTouch authorised in Switzerland?
Yes. Fiasp ultra-fast-acting FlexTouch is authorised by Swissmedic under authorisation number 66200, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Fiasp ultra-fast-acting FlexTouch have?
Fiasp ultra-fast-acting FlexTouch is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Fiasp ultra-fast-acting FlexTouch?
The authorisation holder is Novo Nordisk Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.